Cargando…
Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma
OBJECTIVES: CD133 is considered a cancer stem cell (CSC) marker in various malignancies; however, its role as a biomarker of malignant melanoma remains controversial. The present study was conducted to evaluate the suitability of CD133 surface antigen as a CSC marker in melanoma. METHODS: Human mela...
Autores principales: | Korn, Philippe, Kampmann, Andreas, Spalthoff, Simon, Jehn, Philipp, Tavassol, Frank, Lentge, Fritjof, Gellrich, Nils-Claudius, Zimmerer, Rüdiger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408398/ https://www.ncbi.nlm.nih.gov/pubmed/34048190 http://dx.doi.org/10.31557/APJCP.2021.22.5.1591 |
Ejemplares similares
-
Socio-demographic aspects and treatment-related factors on oral cancer patients’ participation in rehabilitation
por: Korn, Philippe, et al.
Publicado: (2022) -
Novel approach for treating challenging implant-borne maxillary dental rehabilitation cases of cleft lip and palate: a retrospective study
por: Rahlf, Björn, et al.
Publicado: (2022) -
Time is crucial in malignant tumor cases: Speeding up the process of patient-specific implant creation
por: Spalthoff, Simon, et al.
Publicado: (2022) -
Functional features of cancer stem cells in melanoma cell lines
por: Zimmerer, Rüdiger M, et al.
Publicado: (2013) -
Heterotopic bone formation in the musculus latissimus dorsi of sheep using β-tricalcium phosphate scaffolds: evaluation of different seeding techniques
por: Spalthoff, Simon, et al.
Publicado: (2018)